Terns Pharmaceuticals, Inc.
TERN
$6.49
-$0.04-0.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.77% | -9.67% | 0.67% | 3.48% | -1.62% |
| Total Depreciation and Amortization | -36.09% | -21.03% | 3.88% | -14.17% | 1.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.71% | 102.25% | -57.47% | 8.86% | 22.24% |
| Change in Net Operating Assets | 148.08% | -182.43% | 376.28% | -55.63% | 164.86% |
| Cash from Operations | 22.75% | -67.58% | 11.37% | -1.71% | 29.03% |
| Capital Expenditure | -- | -- | -- | 100.00% | 55.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,201.68% | 102.08% | -397.16% | -24.77% | 425.84% |
| Cash from Investing | 1,201.68% | 102.08% | -397.16% | -24.75% | 427.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 337.84% | -88.01% | -99.62% | 40,844.11% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 98.08% | -317.33% | -- | -- |
| Cash from Financing | 376.47% | -77.63% | -99.81% | 40,825.31% | -- |
| Foreign Exchange rate Adjustments | 66.67% | 95.65% | -230.19% | 478.57% | 46.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.97% | 79.38% | -160.85% | 576.74% | 278.03% |